Condition: Venous Vascular Closure · Electrophysiology Study · Sponsor: Cordis US Corp.
The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
This description comes directly from the study's public registry record.
Rajesh Nathan · 908-528-3931 · rajesh.nathan@cordis.com
Jennifer Lee · 559-307-7753 · jennifer.lee02@cordis.com
Always discuss trial participation with your own doctor first.
| South Denver Cardiology | Littleton, Colorado, United States | Recruiting |
| KC Heart and Rhythm Institute | Overland Park, Kansas, United States | Recruiting |
| North Carolina Heart & Vascular Research, LLC | Raleigh, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07246902